According to the inverse association between adiponectin and insulin resistance, and considering diseases such as type 2 diabetes, cardiovascular disease, high blood pressure, metabolic syndrome, and dyslipidemia; it can be assumed that the decrease in adiponectin levels in C-section delivery may increase the risk of the mentioned diseases later in the life of mothers and their neonates. Here, ADIPOQ is linked to cardiovascular disorder.